{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:55:54Z","timestamp":1790819754805,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"DOI":"10.1007\/s11883-026-01468-2","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:54:31Z","timestamp":1790758471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-HDL Cholesterol as a Predictor of Coronary Atherosclerosis in South Asians: A Narrative Review"],"prefix":"10.1007","volume":"28","author":[{"given":"Ashutosh R.","family":"Yaligar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Prasad","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandita","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"1","key":"1468_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000000580","volume":"138","author":"AS Volgman","year":"2018","unstructured":"Volgman AS, Palaniappan LS, Aggarwal NT, et al. Atherosclerotic cardiovascular disease in South Asians in the United States: Epidemiology, Risk factors, and treatments: A scientific statement from the American heart association. Circulation. 2018;138(1):e1\u201334.","journal-title":"Circulation"},{"key":"1468_CR2","doi-asserted-by":"crossref","unstructured":"U N, S D AS. Global burden of cardiovascular disease: What should be expected in the next 25 years? - PubMed. Curr Cardiol Rep. 2026;28(1).","DOI":"10.1007\/s11886-026-02355-7"},{"issue":"7","key":"1468_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11883-023-01110-5","volume":"25","author":"K Gupta","year":"2023","unstructured":"Gupta K, Baloch F, Kakar TS, et al. The pandemic of coronary heart disease in South Asia: What clinicians need to know. Curr. Atheroscler Rep. 2023;25(7):359\u201372.","journal-title":"Curr Atheroscler Rep"},{"issue":"7","key":"1468_CR4","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jacasi.2022.10.005","volume":"2","author":"K Gupta","year":"2022","unstructured":"Gupta K, Modi S, Ananthasubramaniam K. Toward understanding cardiovascular risk burden in South Asians: A major step forward. JACC Asia. 2022;2(7):912\u20135.","journal-title":"JACC Asia"},{"issue":"6","key":"1468_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.052430","volume":"144","author":"AP Patel","year":"2021","unstructured":"Patel AP, Wang M, Kartoun U, Ng K, Khera AV. Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: Results from the UK biobank prospective cohort study. Circulation. 2021;144(6):410\u201322.","journal-title":"Circulation"},{"issue":"4","key":"1468_CR6","doi-asserted-by":"publisher","first-page":"e41221","DOI":"10.1161\/JAHA.124.041221","volume":"15","author":"H Pedamallu","year":"2026","unstructured":"Pedamallu H, Aghabazaz Z, Lancki N, et al. Prevalence and trends in cardiovascular risk factors among middle-aged South Asian adults compared with other racial and ethnic groups in the United States: A Longitudinal analysis of 2 cohort studies. J Am Heart Assoc. 2026;15(4):e41221.","journal-title":"J Am Heart Assoc"},{"key":"1468_CR7","doi-asserted-by":"publisher","unstructured":"Agarwala A, Satish P, Rifai MA, Mehta A, Cainzos-Achirica M, Shah NS, Kanaya AM, Sharma GV, Dixon DL, Blumenthal RS, Natarajan P, Nasir K, Virani SS, Patel J. Identification and management of atherosclerotic cardiovascular disease risk in South Asian populations in the U.S. JACC Adv. 2023;2(2):100258. https:\/\/doi.org\/10.1016\/j.jacadv.2023.100258.\u00a0PubMed PMID: 38089916; PubMed Central PMCID: PMC10715803.","DOI":"10.1016\/j.jacadv.2023.100258"},{"issue":"3","key":"1468_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/jama.297.3.286","volume":"297","author":"P Joshi","year":"2007","unstructured":"Joshi P, Islam S, Pais P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA. 2007;297(3):286\u201394.","journal-title":"JAMA"},{"issue":"5","key":"1468_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11883-007-0047-y","volume":"9","author":"EA Enas","year":"2007","unstructured":"Enas EA, Chacko V, Pazhoor SG, Chennikkara H, Devarapalli HP. Dyslipidemia in South Asian patients. Curr Atheroscler Rep. 2007;9(5):367\u201374.","journal-title":"Curr Atheroscler Rep"},{"issue":"9438","key":"1468_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet"},{"issue":"7","key":"1468_CR11","doi-asserted-by":"publisher","first-page":"101152","DOI":"10.1016\/j.cpcardiol.2022.101152","volume":"48","author":"S Kianoush","year":"2023","unstructured":"Kianoush S, Rifai MA, Jain V, et al. Prevalence and predictors of premature coronary heart disease among asians in the United States: A national health interview survey study. Curr Probl Cardiol. 2023;48(7):101152.","journal-title":"Curr Probl Cardiol"},{"issue":"12","key":"1468_CR12","doi-asserted-by":"publisher","first-page":"101349","DOI":"10.1016\/j.jacadv.2024.101349","volume":"3","author":"A Agarwala","year":"2024","unstructured":"Agarwala A, Satish P, Ma TW, et al. Cardiovascular disease risk in South Asians in the baylor scott and white health DILWALE registry. JACC Adv. 2024;3(12):101349.","journal-title":"JACC Adv"},{"issue":"1","key":"1468_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2014.02.017","volume":"234","author":"AM Kanaya","year":"2014","unstructured":"Kanaya AM, Kandula NR, Ewing SK, et al. Comparing coronary artery calcium among U.S. South Asians with four racial\/ethnic groups: The masala and mesa studies. Atherosclerosis. 2014;234(1):102\u20137.","journal-title":"Atherosclerosis"},{"issue":"15","key":"1468_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/heartjnl-2023-322928","volume":"110","author":"A Rout","year":"2024","unstructured":"Rout A, Duhan S, Umer M, Li M, Kalra D. Atherosclerotic cardiovascular disease risk prediction: current state-of-the-art. Heart. 2024;110(15):1005\u201314.","journal-title":"Heart"},{"key":"1468_CR15","doi-asserted-by":"publisher","first-page":"j2099","DOI":"10.1136\/bmj.j2099","volume":"357","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study. BMJ. 2017;357:j2099.","journal-title":"BMJ"},{"issue":"9","key":"1468_CR16","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/jamacardio.2025.1865","volume":"10","author":"X Yan","year":"2025","unstructured":"Yan X, Bacong AM, Huang Q, et al. Performance of the American Heart association\u2019s prevent equations among disaggregated racial and ethnic subgroups. JAMA Cardiol. 2025;10(9):876\u201385.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"1468_CR17","doi-asserted-by":"publisher","first-page":"e2556915","DOI":"10.1001\/jamanetworkopen.2025.56915","volume":"9","author":"M Au","year":"2026","unstructured":"Au M, Zhang Y, Zhou MM, et al. Prevent equation performance in Asian and native Hawaiian and other Pacific Islander groups. JAMA Netw. Open. 2026;9(2):e2556915\u20132556915.","journal-title":"JAMA Netw Open"},{"key":"1468_CR18","unstructured":"Blumenthal RS, Morris PB, Gaudino M et al. ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: A report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2026."},{"key":"1468_CR19","doi-asserted-by":"crossref","unstructured":"Patel A, Nicholls SJ, Chew DP, et al. Drivers of atherosclerotic cardiovascular disease in South Asians: Current insights and future directions. JACC Asia; 2025.","DOI":"10.1016\/j.jacasi.2025.10.024"},{"issue":"7","key":"1468_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S2213-8587(23)00119-5","volume":"11","author":"RM Anjana","year":"2023","unstructured":"Anjana RM, Unnikrishnan R, Deepa M, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11(7):474\u201389.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1468_CR21","doi-asserted-by":"publisher","first-page":"e96808","DOI":"10.1371\/journal.pone.0096808","volume":"9","author":"SR Joshi","year":"2014","unstructured":"Joshi SR, Anjana RM, Deepa M, et al. Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study. PLoS ONE. 2014;9(5):e96808.","journal-title":"PLoS ONE"},{"issue":"5","key":"1468_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.113.005757","volume":"129","author":"AT Frank","year":"2014","unstructured":"Frank AT, Zhao B, Jose PO, Azar KM, Fortmann SP, Palaniappan LP. Racial\/ethnic differences in dyslipidemia patterns. Circulation. 2014;129(5):570\u20139.","journal-title":"Circulation"},{"issue":"3","key":"1468_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0735-1097(01)01415-2","volume":"38","author":"V Mohan","year":"2001","unstructured":"Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The chennai urban population study (CUPS 5). J Am Coll Cardiol. 2001;38(3):682\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1468_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11883-004-0097-3","volume":"6","author":"DK Kalra","year":"2004","unstructured":"Kalra DK. Homocysteine and cardiovascular disease. Curr Atheroscler Rep. 2004;6(2):101\u20136.","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"1468_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/15701611113119990125","volume":"12","author":"PP Toth","year":"2014","unstructured":"Toth PP. Insulin resistance, small LDL particles, and risk for atherosclerotic disease. Curr. Vasc. Pharmacol. 2014;12(4):653\u20137.","journal-title":"Curr Vasc Pharmacol"},{"issue":"4","key":"1468_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/2047487314528461","volume":"22","author":"S Rashid","year":"2015","unstructured":"Rashid S, Sniderman A, Melone M, et al. Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians. Eur J Prev. Cardiol. 2015;22(4):468\u201377.","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"1468_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11883-004-0050-5","volume":"6","author":"WC Cromwell","year":"2004","unstructured":"Cromwell WC, Otvos JD. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr. Atheroscler Rep. 2004;6(5):381\u20137.","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"1468_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ijo.2015.219","volume":"40","author":"AD Shah","year":"2016","unstructured":"Shah AD, Kandula NR, Lin F, et al. Less favorable body composition and adipokines in South Asians compared with other US ethnic groups: results from the masala and mesa studies. Int J Obes (Lond). 2016;40(4):639\u201345.","journal-title":"Int J Obes (Lond)"},{"key":"1468_CR29","doi-asserted-by":"publisher","unstructured":"Garg SK, Lin F, Kandula N, Ding J, Carr J, Allison M, Liu K, Herrington D, Vaidya D, Vittinghoff E, Kanaya AM. Ectopic fat depots and coronary artery calcium in south asians compared with other racial\/ethnic groups. J Am Heart Assoc. 2016;5(11):e004257. https:\/\/doi.org\/10.1161\/JAHA.116.004257.\u00a0PubMed PMID: 27856485.","DOI":"10.1161\/JAHA.116.004257"},{"issue":"3","key":"1468_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jacl.2021.03.007","volume":"15","author":"D Kalra","year":"2021","unstructured":"Kalra D, Vijayaraghavan K, Sikand G, et al. Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association. J Clin Lipidol. 2021;15(3):402\u201322.","journal-title":"J Clin Lipidol"},{"issue":"3","key":"1468_CR31","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/j.jacl.2024.01.006","volume":"18","author":"R Puri","year":"2024","unstructured":"Puri R, Bansal M, Mehta V, et al. Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV. J Clin. Lipidol. 2024;18(3):e351\u201373.","journal-title":"J Clin Lipidol"},{"issue":"11","key":"1468_CR32","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1161\/01.ATV.19.11.2749","volume":"19","author":"KR Kulkarni","year":"1999","unstructured":"Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP. Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol. 1999;19(11):2749\u201355.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1468_CR33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jacc.2021.11.042","volume":"79","author":"A Sajja","year":"2022","unstructured":"Sajja A, Li HF, Spinelli KJ, et al. Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis. J Am Coll Cardiol. 2022;79(6):530\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"1468_CR34","doi-asserted-by":"publisher","first-page":"117312","DOI":"10.1016\/j.atherosclerosis.2023.117312","volume":"383","author":"V Raja","year":"2023","unstructured":"Raja V, Aguiar C, Alsayed N, et al. Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. Atherosclerosis. 2023;383:117312.","journal-title":"Atherosclerosis"},{"key":"1468_CR35","doi-asserted-by":"publisher","unstructured":"Abramov D, Minhas AMK, Shapiro MD, Bittner VA, Brewer LC, Gianos E, Mora S, Mehta LS, Kulkarni A, Kalra DK, Slipczuk L, Virani SS. Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC\/AHA Multisociety Guideline. Curr Atheroscler Rep. 2026;28(1):63. https:\/\/doi.org\/10.1007\/s11883-026-01437-9.\u00a0PubMed PMID: 42295619.","DOI":"10.1007\/s11883-026-01437-9"},{"issue":"10215","key":"1468_CR36","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(19)32519-X","volume":"394","author":"FJ Brunner","year":"2019","unstructured":"Brunner FJ, Waldeyer C, Ojeda F, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational cardiovascular risk consortium. Lancet. 2019;394(10215):2173\u201383.","journal-title":"Lancet"},{"issue":"12","key":"1468_CR37","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1001\/jama.2012.366","volume":"307","author":"SM Boekholdt","year":"2012","unstructured":"Boekholdt SM, Arsenault BJ, Mora S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012;307(12):1302\u20139.","journal-title":"JAMA"},{"issue":"3","key":"1468_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","volume":"4","author":"AD Sniderman","year":"2011","unstructured":"Sniderman AD, Williams K, Contois JH, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b as markers of cardiovascular risk. Circ Cardiovasc Qual. Outcomes. 2011;4(3):337\u201345.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"21","key":"1468_CR39","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.jacc.2013.07.045","volume":"62","author":"MB Elshazly","year":"2013","unstructured":"Elshazly MB, Martin SS, Blaha MJ, et al. Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: The VLDL-2 study (very large database of lipids). J Am Coll Cardiol. 2013;62(21):1960\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1468_CR40","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamacardio.2020.7238","volume":"6","author":"MK Armstrong","year":"2021","unstructured":"Armstrong MK, Fraser BJ, Hartiala O, et al. Association of non-high-density lipoprotein cholesterol measured in adolescence, young adulthood, and mid-adulthood with coronary artery calcification measured in mid-adulthood. JAMA Cardiol. 2021;6(6):661\u20138.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"1468_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.amjcard.2013.10.027","volume":"113","author":"SK Zalawadiya","year":"2014","unstructured":"Zalawadiya SK, Veeranna V, Panaich S, Kottam A, Afonso L. Non-high-density lipoprotein cholesterol and coronary artery calcium progression in a multiethnic US population. Am J Cardiol. 2014;113(3):471\u20134.","journal-title":"Am J Cardiol"},{"issue":"1","key":"1468_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2008.03.014","volume":"202","author":"SH Orakzai","year":"2009","unstructured":"Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis. 2009;202(1):289\u201395.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1468_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jcct.2013.01.008","volume":"7","author":"R Nakazato","year":"2013","unstructured":"Nakazato R, Gransar H, Berman DS, et al. Relationship of low- and high-density lipoproteins to coronary artery plaque composition by CT angiography. J Cardiovasc Comput Tomogr. 2013;7(2):83\u201390.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"11","key":"1468_CR44","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/ATVBAHA.116.307601","volume":"36","author":"R Puri","year":"2016","unstructured":"Puri R, Nissen SE, Shao M, et al. Non-HDL Cholesterol and triglycerides: Implications for coronary atheroma progression and clinical events. Arterioscler Thromb Vasc Biol. 2016;36(11):2220\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1468_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jacc.2008.09.041","volume":"53","author":"G Karthikeyan","year":"2009","unstructured":"Karthikeyan G, Teo KK, Islam S, et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the interhearT Study. J Am Coll Cardiol. 2009;53(3):244\u201353.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1468_CR46","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.jacl.2025.09.008","volume":"19","author":"EM Manghis","year":"2025","unstructured":"Manghis EM, Gadgil MD, Budoff M, Kandula NR, Kanaya AM. Remnant cholesterol and associations with incidence, progression, and change in coronary artery calcium in South Asian Americans. J Clin Lipidol. 2025;19(6):1679\u201386.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"1468_CR47","doi-asserted-by":"publisher","first-page":"e011053","DOI":"10.1161\/JAHA.118.011053","volume":"8","author":"AM Kanaya","year":"2019","unstructured":"Kanaya AM, Vittinghoff E, Lin F, et al. Incidence and progression of coronary artery calcium in South Asians compared with 4 race\/ethnic groups. J Am Heart Assoc. 2019;8(2):e011053.","journal-title":"J Am Heart Assoc"},{"key":"1468_CR48","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.ajpc.2022.100453","volume":"13","author":"H Shah","year":"2023","unstructured":"Shah H, Garacci E, Behuria S, et al. Cardiovascular risk-enhancing factors and coronary artery calcium in South Asian American adults: The masala study. Am J Prev Cardiol. 2023;13:100453.","journal-title":"Am J Prev Cardiol"},{"key":"1468_CR49","doi-asserted-by":"publisher","unstructured":"Kalra DK. Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation. Prog Cardiovasc Dis. 2026;96:76\u20138. https:\/\/doi.org\/10.1016\/j.pcad.2026.06.002.\u00a0PubMed PMID: 42342007.","DOI":"10.1016\/j.pcad.2026.06.002"},{"key":"1468_CR50","doi-asserted-by":"crossref","unstructured":"Abdul Jabbar AB, Naeem U, Zulfiqar K et al. Highlights of cardiovascular disease prevention studies presented at the 2026 American college of cardiology conference. Curr Atheroscler Rep. 2026;28(1).","DOI":"10.1007\/s11883-026-01424-0"},{"issue":"1","key":"1468_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-med-050124-025051","volume":"77","author":"ML Koschinsky","year":"2026","unstructured":"Koschinsky ML, Kalra DK, Boffa MB. Lipoprotein(a): An Underappreciated Inherited Risk Factor for Atherosclerosis, Aortic Stenosis, and Abdominal Aortic Aneurysm. Annu Rev Med. 2026;77(1):31\u201343.","journal-title":"Annu Rev Med"},{"key":"1468_CR52","doi-asserted-by":"publisher","unstructured":"Balaji K, Chahil V, Shakoor A, Kalra D, Vijayaraghavan K. Inflammation and cardiometabolic disease in South Asians: The fire and fire tenders. J Clin Lipidol. 2025;S1933\u20132874(25)00497\u20130. https:\/\/doi.org\/10.1016\/j.jacl.2025.10.068. PubMed PMID: 41444042.","DOI":"10.1016\/j.jacl.2025.10.068"},{"key":"1468_CR53","doi-asserted-by":"publisher","unstructured":"Kalra DK. A deeper dive into the REPRIEVE trial and the potential role of inflammation in residual risk. J Clin Lipidol. 2023;17(5):563\u20136. https:\/\/doi.org\/10.1016\/j.jacl.2023.09.006.\u00a0PubMed PMID: 37783647.","DOI":"10.1016\/j.jacl.2023.09.006"},{"issue":"1","key":"1468_CR54","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","volume":"42","author":"G Reyes-Soffer","year":"2022","unstructured":"Reyes-Soffer G, Ginsberg HN, Berglund L, et al. Lipoprotein(a): A genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: A scientific statement from the American heart association. Arterioscler Thromb Vasc Biol. 2022;42(1):e48\u201360.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"1468_CR55","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/phar.2851","volume":"43","author":"IS Alhomoud","year":"2023","unstructured":"Alhomoud IS, Talasaz A, Mehta A, et al. Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies. Pharmacotherapy. 2023;43(10):1051\u201363.","journal-title":"Pharmacotherapy"},{"issue":"7","key":"1468_CR56","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","volume":"7","author":"F Duarte Lau","year":"2022","unstructured":"Duarte Lau F, Giugliano RP. Lipoprotein(a) and its significance in cardiovascular disease: A review. JAMA Cardiol. 2022;7(7):760\u20139.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"1468_CR57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","volume":"41","author":"AP Patel","year":"2021","unstructured":"Patel AP, Wang M, Pirruccello JP, et al. Lp(a) (Lipoprotein[a]) Concentrations and incident atherosclerotic cardiovascular disease: New insights from a large national biobank. Arterioscler. Thromb Vasc Biol. 2021;41(1):465\u201374.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"1468_CR58","doi-asserted-by":"publisher","first-page":"eJAHA2024040361","DOI":"10.1161\/JAHA.124.040361","volume":"14","author":"D Patel","year":"2025","unstructured":"Patel D, Koschinsky ML, Agarwala A, et al. Role of lipoprotein(a) in atherosclerotic cardiovascular disease in South Asian Individuals. J Am Heart Assoc. 2025;14(14):eJAHA2024040361T.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"1468_CR59","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","volume":"139","author":"G Par\u00e9","year":"2019","unstructured":"Par\u00e9 G, \u00c7aku A, McQueen M, et al. Lipoprotein(a) levels and the Risk of myocardial infarction among 7 ethnic groups. Circulation. 2019;139(12):1472\u201382.","journal-title":"Circulation"},{"issue":"6","key":"1468_CR60","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.amjcard.2018.12.013","volume":"123","author":"MD Huffman","year":"2019","unstructured":"Huffman MD, Kandula NR, Baldridge AS, Tsai MY, Prabhakaran D, Kanaya AM. Evaluating the potential association between lipoprotein(a) and atherosclerosis (from the mediators of atherosclerosis among South Asians living in America Cohort). Am J Cardiol. 2019;123(6):919\u201321.","journal-title":"Am J Cardiol"},{"key":"1468_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2020.09.010","volume":"313","author":"M Makshood","year":"2020","unstructured":"Makshood M, Joshi PH, Kanaya AM, et al. Lipoprotein (a) and aortic valve calcium in South Asians compared to other race\/ethnic groups. Atherosclerosis. 2020;313:14\u20139.","journal-title":"Atherosclerosis"},{"issue":"1","key":"1468_CR62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10557-022-07407-y","volume":"38","author":"RS Rosenson","year":"2024","unstructured":"Rosenson RS, L\u00f3pez JAG, Monsalvo ML, Wu Y, Wang H, Marcovina SM. Quantification of LDL-cholesterol corrected for molar concentration of lipoprotein(a). Cardiovasc Drugs Ther. 2024;38(1):191\u20137.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"1468_CR63","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jacl.2022.03.008","volume":"16","author":"R Puri","year":"2022","unstructured":"Puri R, Mehta V, Duell PB, et al. Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the lipid association of India. J Clin Lipidol. 2022;16(3):261\u201371.","journal-title":"J Clin Lipidol"},{"issue":"9","key":"1468_CR64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5005\/japi-11001-0110","volume":"70","author":"V Mehta","year":"2022","unstructured":"Mehta V, Puri R, Duell PB, et al. Unmet Need for further LDL-C lowering in India despite Statin therapy: Lipid Association of India recommendations for the Use of bempedoic Acid. J Assoc. Physicians India. 2022;70(9):11\u20132.","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"1468_CR65","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacl.2020.01.011","volume":"14","author":"V Nambi","year":"2020","unstructured":"Nambi V, Sikand G, Kalra D, Vijayaraghavan K. Low-density lipoprotein cholesterol goals in the secondary prevention of cardiovascular diseases in the Indian population-Is 30 the new 70? J Clin Lipidol. 2020;14(2):173\u20135.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"1468_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl. J Med. 2019;380(1):11\u201322.","journal-title":"N Engl J Med"},{"issue":"13","key":"1468_CR67","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMoa2507227","volume":"393","author":"BA Bergmark","year":"2025","unstructured":"Bergmark BA, Marston NA, Prohaska TA, et al. Targeting APOC3 with olezarsen in moderate hypertriglyceridemia. N Engl. J Med. 2025;393(13):1279\u201391.","journal-title":"N Engl J Med"},{"issue":"7","key":"1468_CR68","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/jamacardio.2024.0959","volume":"9","author":"D Gaudet","year":"2024","unstructured":"Gaudet D, Pall D, Watts GF, et al. Plozasiran (ARO-APOC3) for severe hypertriglyceridemia: The SHASTA-2 Randomized clinical trial. JAMA Cardiol. 2024;9(7):620\u201330.","journal-title":"JAMA Cardiol"},{"key":"1468_CR69","doi-asserted-by":"crossref","unstructured":"Kalra DK, Ray KK, Bajaj A et al. Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials: A meta-analysis. J Clin Lipidol. 2026;20(4).","DOI":"10.1016\/j.jacl.2026.02.006"},{"key":"1468_CR70","doi-asserted-by":"publisher","unstructured":"Gupta K, Al Rifai M, Hussain A, Minhas AMK, Patel J, Kalra D, Samad Z, Virani SS. South Asian ethnicity: What can we do to make this risk enhancer a risk equivalent? Prog Cardiovasc Dis. 2022;75:21\u201332. https:\/\/doi.org\/10.1016\/j.pcad.2022.10.001.\u00a0PubMed PMID: 36279943.","DOI":"10.1016\/j.pcad.2022.10.001"},{"issue":"11","key":"1468_CR71","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/eurjpc\/zwad030","volume":"30","author":"S Sawant","year":"2023","unstructured":"Sawant S, Wang N. Under-representation of ethnic and regional minorities in lipid-lowering randomized clinical trials: A systematic review and meta-analysis. Eur J Prev. Cardiol. 2023;30(11):1120\u201331.","journal-title":"Eur J Prev Cardiol"},{"key":"1468_CR72","doi-asserted-by":"crossref","unstructured":"Kalra DK, Heo R, Valenti V, Nakazato R, Min JK. Role of computed tomography for diagnosis and risk stratification of patients with suspected or known coronary artery disease. Arterioscler Thromb Vasc Biol. 2014;34(6).","DOI":"10.1161\/ATVBAHA.113.302074"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-026-01468-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:03:39Z","timestamp":1790816619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-026-01468-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s11883-026-01468-2","relation":{},"ISSN":["1534-6242"],"issn-type":[{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"29 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No animal or human subjects were used by the authors in this study.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"97"}}